Our work on remote control T cells for cancer immunotherapy was recently published in ACS Synthetic Biology! Engineered T cell therapies are a new class of treatments that have the potential to cure patients of cancer. However, tumors have the uncanny ability to turn off T cells to evade being targeted. In our study, we developed a new technique to remotely activate T cells, which were genetically modified, using laser targeting and pulses of heat.
Our study was highlighted by numerous news outlets – read more about this technology below.
ASME: Precisely targeting tumors with cancer fighting T cells
Georgia Tech Research Horizons: Remote-control shoots laser at nano-gold to turn on cancer-killing immune cells
Medical News Today: This ‘genetic switch’ could help fight cancer